Pfizer's Breakthrough Growth Initiative has backed the PureTech microbiome spinoff, which will use the cash to finance phase 2 tests of its lead IBD drug candidate.

Fivestar Holdings took part in a series B round for the early education platform developer through investment vehicle Focustar Capital.

The transistor technology developer has disclosed $21.8m in series A funding from investors including Agilent Technologies across three tranches.

American Family’s venture capital unit has contributed to a $22.5m round that will support the digital mortgage lender's US expansion.

Existing investor SoftBank Ventures Asia helped the online investment platform developer close a round that will fund its growth in Indonesia.

Lilly Asia Ventures has led a $23.2m round for the digital diagnostics technology developer, investing alongside new and existing backers.

Cambrian Biopharma returned to back the immunotherapy developer's series B round, following its series A three months ago.

ADM Ventures, GV and Barclays helped the microbe-based protein developer close a round that will support research and development.

Takeda Digital Ventures, Humana, McKesson Ventures and dRx Capital backed the online pharmacy platform developer's series B round.

Fidelity provided a $4.8m second tranche after a first close featuring KNC, Ohar Pharmaceutical, Spera Pharma, Kisco and SRD Holdings.